Published in Arch Intern Med on January 23, 2006
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med (2009) 65.36
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ (2009) 34.99
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ (2009) 22.18
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med (2009) 21.74
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. Open Med (2009) 4.43
Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines. Eur Radiol (2011) 3.14
Evaluation and initial management of acute kidney injury. Clin J Am Soc Nephrol (2008) 1.83
Sodium bicarbonate is associated with an increased incidence of contrast nephropathy: a retrospective cohort study of 7977 patients at mayo clinic. Clin J Am Soc Nephrol (2007) 1.68
A meta-analysis of N-acetylcysteine in contrast-induced nephrotoxicity: unsupervised clustering to resolve heterogeneity. BMC Med (2007) 1.19
Sodium bicarbonate for the prevention of contrast induced-acute kidney injury: a systematic review and meta-analysis. Clin J Am Soc Nephrol (2009) 1.03
Acute kidney injury in the elderly. Clin Geriatr Med (2009) 1.01
Efficacy of N-acetylcysteine in preventing renal injury after heart surgery: a systematic review of randomized trials. Eur Heart J (2009) 0.83
Section 4: Contrast-induced AKI. Kidney Int Suppl (2011) (2012) 0.82
Contrast-induced nephropathy: pathogenesis and prevention. Pediatr Nephrol (2009) 0.82
Mechanisms for an effect of acetylcysteine on renal function after exposure to radio-graphic contrast material: study protocol. BMC Clin Pharmacol (2012) 0.81
N-acetylcysteine for contrast nephropathy: more clinical science is required. Arch Intern Med (2006) 0.76
From chaotic to coordinated clinical research: the case of acetylcysteine. Arch Intern Med (2006) 0.75
Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care (2005) 30.41
The Canadian Adverse Events Study: the incidence of adverse events among hospital patients in Canada. CMAJ (2004) 21.24
Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology (2011) 12.09
Relation between kidney function, proteinuria, and adverse outcomes. JAMA (2010) 8.26
Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis. JAMA (2007) 7.79
New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality. J Clin Epidemiol (2004) 7.20
Structured telephone support or telemonitoring programmes for patients with chronic heart failure. Cochrane Database Syst Rev (2010) 6.49
D-dimer for the exclusion of acute venous thrombosis and pulmonary embolism: a systematic review. Ann Intern Med (2004) 6.15
Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis. BMJ (2011) 6.11
Validity of information on comorbidity derived rom ICD-9-CCM administrative data. Med Care (2002) 5.92
Physician wellness: a missing quality indicator. Lancet (2009) 5.50
Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial. JAMA (2007) 5.31
Comparison of the Elixhauser and Charlson/Deyo methods of comorbidity measurement in administrative data. Med Care (2004) 5.12
Re-examining the efficacy of beta-blockers for the treatment of hypertension: a meta-analysis. CMAJ (2006) 5.03
Telemonitoring or structured telephone support programmes for patients with chronic heart failure: systematic review and meta-analysis. BMJ (2007) 5.02
Contemporary management of chronic obstructive pulmonary disease: scientific review. JAMA (2003) 4.88
Meta-analysis: secondary prevention programs for patients with coronary artery disease. Ann Intern Med (2005) 4.85
Improved clinical outcomes associated with metformin in patients with diabetes and heart failure. Diabetes Care (2005) 4.78
Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12 065 patients with new-onset heart failure. Circulation (2003) 4.43
Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study. Lancet (2012) 4.25
Assessing validity of ICD-9-CM and ICD-10 administrative data in recording clinical conditions in a unique dually coded database. Health Serv Res (2008) 4.25
Validity of procedure codes in International Classification of Diseases, 9th revision, clinical modification administrative data. Med Care (2004) 4.15
Benefits and harms of antidiabetic agents in patients with diabetes and heart failure: systematic review. BMJ (2007) 3.95
New evidence for stroke prevention: scientific review. JAMA (2002) 3.70
The reporting of methodological factors in randomized controlled trials and the association with a journal policy to promote adherence to the Consolidated Standards of Reporting Trials (CONSORT) checklist. Control Clin Trials (2002) 3.62
Statins and outcomes in patients admitted to hospital with community acquired pneumonia: population based prospective cohort study. BMJ (2006) 3.62
Adapting the Charlson Comorbidity Index for use in patients with ESRD. Am J Kidney Dis (2003) 3.60
Accuracy of administrative databases in identifying patients with hypertension. Open Med (2007) 3.56
Using proteinuria and estimated glomerular filtration rate to classify risk in patients with chronic kidney disease: a cohort study. Ann Intern Med (2011) 3.49
Implantable cardioverter defibrillators in primary and secondary prevention: a systematic review of randomized, controlled trials. Ann Intern Med (2003) 3.43
Intensive and Standard Blood Pressure Targets in Patients With Type 2 Diabetes Mellitus: Systematic Review and Meta-analysis. Arch Intern Med (2012) 3.26
Body mass index and mortality in heart failure: a meta-analysis. Am Heart J (2008) 3.25
A randomized trial of the effect of community pharmacist and nurse care on improving blood pressure management in patients with diabetes mellitus: study of cardiovascular risk intervention by pharmacists-hypertension (SCRIP-HTN). Arch Intern Med (2008) 3.21
Survival after coronary revascularization in the elderly. Circulation (2002) 3.17
A meta-analysis of the effect of exercise training on left ventricular remodeling in heart failure patients: the benefit depends on the type of training performed. J Am Coll Cardiol (2007) 3.16
Using effectiveness and cost-effectiveness to make drug coverage decisions: a comparison of Britain, Australia, and Canada. JAMA (2009) 3.11
Cost analysis of ongoing care of patients with end-stage renal disease: the impact of dialysis modality and dialysis access. Am J Kidney Dis (2002) 3.06
Early risk of stroke after transient ischemic attack: a systematic review and meta-analysis. Arch Intern Med (2007) 3.06
Glomerular filtration rate, proteinuria, and the incidence and consequences of acute kidney injury: a cohort study. Lancet (2010) 2.95
Declining in-hospital mortality and increasing heart failure incidence in elderly patients with first myocardial infarction. J Am Coll Cardiol (2009) 2.82
Dealing with missing data in a multi-question depression scale: a comparison of imputation methods. BMC Med Res Methodol (2006) 2.81
Validation of a case definition to define hypertension using administrative data. Hypertension (2009) 2.74
Characteristics and outcomes of patients with acute myocardial infarction and angiographically normal coronary arteries. Am J Cardiol (2005) 2.69
Preoperative hypernatremia predicts increased perioperative morbidity and mortality. Am J Med (2013) 2.69
Nephrology visits and health care resource use before and after reporting estimated glomerular filtration rate. JAMA (2010) 2.61
Overview of the Alberta Kidney Disease Network. BMC Nephrol (2009) 2.58
An observational study found that authors of randomized controlled trials frequently use concealment of randomization and blinding, despite the failure to report these methods. J Clin Epidemiol (2004) 2.58
Evidence of suboptimal management of cardiovascular risk in patients with type 2 diabetes mellitus and symptomatic atherosclerosis. CMAJ (2004) 2.55
Pharmacist care of patients with heart failure: a systematic review of randomized trials. Arch Intern Med (2008) 2.55
Transition from meeting abstract to full-length journal article for randomized controlled trials. JAMA (2006) 2.53
Impact of specialist follow-up in outpatients with congestive heart failure. CMAJ (2005) 2.50
Statins are associated with better outcomes after carotid endarterectomy in symptomatic patients. Stroke (2005) 2.50
Prevention of dialysis catheter malfunction with recombinant tissue plasminogen activator. N Engl J Med (2011) 2.48
Rates of treated and untreated kidney failure in older vs younger adults. JAMA (2012) 2.43
Preoperative hyponatremia and perioperative complications. Arch Intern Med (2012) 2.42
Efficacy of statins for primary prevention in people at low cardiovascular risk: a meta-analysis. CMAJ (2011) 2.40
Mycophenolate mofetil for induction therapy of lupus nephritis: a systematic review and meta-analysis. Clin J Am Soc Nephrol (2007) 2.38
Aldosterone blockade and left ventricular dysfunction: a systematic review of randomized clinical trials. Eur Heart J (2008) 2.37
Does performance-based remuneration for individual health care practitioners affect patient care?: a systematic review. Ann Intern Med (2012) 2.35
Meta-analysis: cardiac resynchronization therapy for patients with less symptomatic heart failure. Ann Intern Med (2011) 2.34
The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease. J Am Coll Cardiol (2004) 2.32
Mortality and readmission of patients with heart failure, atrial fibrillation, or coronary artery disease undergoing noncardiac surgery: an analysis of 38 047 patients. Circulation (2011) 2.30
Cardiac rehabilitation attendance and outcomes in coronary artery disease patients. Circulation (2012) 2.30
Hospital and surgeon determinants of carotid endarterectomy outcomes. Arch Neurol (2002) 2.30
The effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a systematic review of randomized placebo-controlled trials. Am J Med (2002) 2.26
Increases in antihypertensive prescriptions and reductions in cardiovascular events in Canada. Hypertension (2008) 2.23
Stroke: strategies for primary prevention. Am Fam Physician (2003) 2.19
Effectiveness of interventions targeting frequent users of emergency departments: a systematic review. Ann Emerg Med (2011) 2.19
Development of a frailty index for patients with coronary artery disease. J Am Geriatr Soc (2010) 2.18
CKD and risk of hospitalization and death with pneumonia. Am J Kidney Dis (2009) 2.17
Proteinuria and life expectancy. Am J Kidney Dis (2012) 2.16
From knowledge to practice in chronic cardiovascular disease: a long and winding road. J Am Coll Cardiol (2004) 2.16
The impact of the Canadian Hypertension Education Program on antihypertensive prescribing trends. Hypertension (2005) 2.15
Cross-national comparative performance of three versions of the ICD-10 Charlson index. Med Care (2007) 2.14
Outcomes after aortic and mitral valve replacement surgery in Canada: 1994/95 to 1999/2000. Can J Cardiol (2004) 2.11
Impact of anemia on hospitalization and mortality in older adults. Blood (2006) 2.07
Higher estimated glomerular filtration rates may be associated with increased risk of adverse outcomes, especially with concomitant proteinuria. Kidney Int (2011) 2.07
Defining the optimal treatment of locally advanced esophageal cancer: a systematic review and decision analysis. Ann Thorac Surg (2007) 2.06
Meta-analysis: antibiotics for prophylaxis against hemodialysis catheter-related infections. Ann Intern Med (2008) 2.06
Aspirin use and outcomes in a community-based cohort of 7352 patients discharged after first hospitalization for heart failure. Circulation (2006) 2.05
The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: part II - therapy. Can J Cardiol (2005) 2.03
Cardiovascular outcomes in framingham participants with diabetes: the importance of blood pressure. Hypertension (2011) 2.02
A systematic review of drug therapy to delay or prevent type 2 diabetes. Diabetes Care (2005) 2.01
The 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy. Can J Cardiol (2007) 2.01
Heart failure is a risk factor for orthopedic fracture: a population-based analysis of 16,294 patients. Circulation (2008) 1.98
Overview of a formal scoping review on health system report cards. Implement Sci (2010) 1.95
Blood pressure in Canadian adults. Health Rep (2010) 1.93
Access to health care among status Aboriginal people with chronic kidney disease. CMAJ (2008) 1.91
Chronic kidney disease and life expectancy. Nephrol Dial Transplant (2012) 1.90